Skip to main content
GutCited
Figure 19

Descripción

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

More Figures from This Paper

Correlation analysis between gut microbiota changes and hepatic inflammation markers in berberine-treated mice with autoimmune hepatitis.

Figure 8

Correlation analysis between gut microbiota changes and hepatic inflammation markers in berberine-treated mice with autoimmune hepatitis.

chart
Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

Figure 11

Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

chart
Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

Figure 17

Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

diagram
Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Figure 18

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart
Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Figure 20

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart
Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Figure 29

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

chart

Figure 19

Chart
520 × 389px · 270,8 KB

Source Paper

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.

Hepatology communications (2024)

PMID: 38466881

DOI: 10.1097/HC9.0000000000000381

Cite This Figure

![Figure 19: Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.](https://pdfs.citedhealth.com/figures/38466881/459.png)

> Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." *Hepatology communications*, 2024. PMID: [38466881](https://pubmed.ncbi.nlm.nih.gov/38466881/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/38466881/459.png" alt="Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function." />
  <figcaption>Figure 19. Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.<br>  Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." <em>Hepatology communications</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38466881/">38466881</a></figcaption>
</figure>

Evidencia relacionada

D
Berberine para Gut Dysbiosis

Calificación D · 2 estudios